Part,  Chapter, Paragraph

 1   II,     5.  4.  8|         Jönsson B (2002), CODE-2 Advisory Board, Revealing the cost
 2   II,     5.  5.  3|         Sclerosis Society (USA): Advisory Committee on Clinical Trials
 3   II,     5. 10.  6|    labelling. The restriction of advisory labelling statements only
 4  III,    10.  4.  2|       safety authorities via the Advisory Forum Communications Working
 5  III,    10.  4.  2|        multi-disciplinary expert Advisory Group on Risk Communications,
 6  III,    10.  5.  3|       the UK Industrial Injuries Advisory Council (Walters, 2007).~ ~
 7   IV,    11.  6.  4| categorized as serving either an advisory or regulatory role in the
 8   IV,    12. 10    |  recommendations of the~National Advisory Committee on Drugs~(NACD)
 9   IV,    12. 10    |      2008.~ ~NACD - The National Advisory Committee~on Drugs in September
10   IV,    12. 10    |   mechanisms includes a national advisory board, and three bodies
11   IV,    13.  6.  2|          across Europe, concerns advisory, preventive, and screening
12   IV,    13.  6.  2|      difficult to achieve.~ ~The advisory role of the school health
13   IV,    13.  7.  5|         Party, an independent EU Advisory Body on Data Protection